Helping to ensure accurate testing for early detection of genetic diseases
Every state in the United States screens newborn babies for many serious but treatable genetic diseases. This screening can make the difference between life and death for some newborns, and helps those with genetic diseases get treatments they need to avoid life-long health problems.
You can help ensure that newborn screening is accurate and reliable.
ABOUT THE NEWBORN SCREENING ACCURACY PROJECT
The Newborn Screening Accuracy (NBSA) Project, a Sequoia Foundation program funded by The Centers for Disease Control and Prevention (CDC), helps CDC ensure that newborn screening tests are accurate so that babies with genetic diseases can be diagnosed and treated early in life. The CDC is working with the Sequoia Foundation and specialty care clinics to collect blood samples from children and adults who have already been diagnosed with a disease detectable during the newborn period. The blood samples are used to create quality assurance materials that laboratories can use to check if their screening tests can accurately detect diseases. The samples can also be used to develop new screening tests so even more babies can benefit.
